MDG1 fundamentals
An in-depth look to MEDIGENE AG operating, investing, and financing activities
MDG1 free cash flow for H2 23 is -6.88 M CHF. For 2023, MDG1 free cash flow was -14.67 M CHF and operating cash flow was -14.05 M CHF.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
TTM